2013Military Medical Journal of South ChinaRequires access

Transcathater Arterial Chemoembolization in the Prevention of Postoperative Recurrence in Patients with Hepatocellular Carcinoma

LI Gui-hu

Open publisher page 0 citations

Abstract

Objective To evaluate the effect of transcathater arterial chemoembolization(TACE) in preventing postoperative recurrence of hepatocellular carcinoma and provide evidence to decrease the postoperative recurrence.Methods A total of 158 patients with hepatocellular carcinoma who received complete surgical removal were studied.Eighty-four cases receiving TACE at 30 days after surgery were TACE group and the remaining 74 cases without TACE were control group.All patients were follow-upped in the outpatient department or by telephone.The 1-,2-and 3-year cumulative recurrence rate and 1-,2-and 3-year cumulative survival rate of the two groups were compared.Results The follow-up rate was 95.2% in TACE group,and 95.9% in control group.The 1-,2-,and 3-year cumulative recurrence rates were 10.0%,45.0%,67.5% in TACE group,and 45.1%,66.2%,84.5% in control group.The differences were statistically significant(P0.05).The 1-,2-,3-year cumulative survival rates were 85.0%,72.5%,62.5% in TACE group and 70.4%,56.3%,45.1% in control group.The differences were statistically significant(P0.05).ConclusionPostoperative TACE avails to early detect the residual foci,reduce the recurrence rate and improve patients' survival rate.

About this research paper

What this paper is about

Objective To evaluate the effect of transcathater arterial chemoembolization(TACE) in preventing postoperative recurrence of hepatocellular carcinoma and provide evidence to decrease the postoperative recurrence.Methods A total of 158 patients with hepatocellular carcinoma who received complete surgical removal were studied.Eighty-four cases receiving TACE at 30 days after surgery were TACE group and the remaining 74 cases without TACE were control group.All patients were follow-upped in the outpatient department or by telephone.The 1-,2-and 3-year cumulative recurrence rate and 1-,2-and 3-year cumulative survival rate of the two groups were compared.Results The follow-up rate was 95.2% in TACE group,and 95.9% in control group.The 1-,2-,and 3-year cumulative recurrence rates were 10.0%,45.0%,67.5% in TACE group,and 45.1%,66.2%,84.5% in control group.The differences were statistically significant(P0.05).The 1-,2-,3-year cumulative survival rates were 85.0%,72.5%,62.5% in TACE group and 70.4%,56.3%,45.1% in control group.The differences were statistically significant(P0.05).ConclusionPostoperative TACE avails to early detect the residual foci,reduce the recurrence rate and improve patients' survival rate.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effect of transcathater arterial chemoembolization(TACE) in preventing postoperative recurrence of hepatocellular carcinoma and provide evidence to decrease the postoperative recurrence.Methods A total of 158 patients with hepatocellular carcinoma who received complete surgical removal were studied.Eighty-four cases receiving TACE at 30 days after surgery were TACE group and the remaining 74 cases without TACE were control group.All patients were follow-upped in the outpatient department or by telephone.The 1-,2-and 3-year cumulative recurrence rate and 1-,2-and 3-year cumulative survival rate of the two groups were compared.Results The follow-up rate was 95.2% in TACE group,and 95.9% in control group.The 1-,2-,and 3-year cumulative recurrence rates were 10.0%,45.0%,67.5% in TACE group,and 45.1%,66.2%,84.5% in control group.The differences were statistically significant(P0.05).The 1-,2-,3-year cumulative survival rates were 85.0%,72.5%,62.5% in TACE group and 70.4%,56.3%,45.1% in control group.The differences were statistically significant(P0.05).ConclusionPostoperative TACE avails to early detect the residual foci,reduce the recurrence rate and improve patients' survival rate.

Key concepts: Medicine, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Surgery, Internal medicine, Gastroenterology, Survival rate, Carcinoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Transcathater Arterial Chemoembolization in the Prevention of Postoperative Recurrence in Patients with Hepatocellular Carcinoma — Research Paper | ScholarLens